Publications

Publications

Filter Results: (29) Arrow Down

Show Results For

Page 1 of 29 Results →
  • 2019
  • Chapter

Characterizing the Drug Development Pipeline for Precision Medicines

By: Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
BOOK ABSTRACT: Personalized and precision medicine (PPM)—the targeting of therapies according to an individual’s genetic, environmental, or lifestyle characteristics—is becoming an increasingly important approach in health care treatment and prevention. The advancement... View Details
Keywords: Healthcare; Precision Medicine
Related
  • 06 Sep 2022
  • Research & Ideas

Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations

Prescription drug costs continue to climb in the United States, but tightening a loophole in a federal law may help curb rising expenses, according to research published this week in Health Affairs. Efforts to control US health care... View Details
Keywords: by Ben Rand; Insurance; Health; Pharmaceutical
  • October 2013
  • Case

FasterCures: Removing Barriers to Treatments

By: Richard G. Hamermesh and James Weber

In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details

Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Related
  • March 2014
  • Editorial

Limits on Use of Health Economic Assessments for Rare Diseases

By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Keywords: Cost; Health Disorders; Health Care and Treatment; Pharmaceutical Industry
Related
  • 2023
  • Article

Dynamic HTA for Digital Health Solutions: Opportunities and Challenges for Patient-Centered Evaluation

By: Jan B. Brönneke, Annika Herr, Simon Reif and Ariel D. Stern
Germany’s 2019 Digital Healthcare Act (Digitale-Versorgung-Gesetz, or DVG) created a number of opportunities for the digital transformation of the health care delivery system. Key among these was the creation of a reimbursement pathway for patient-centered digital... View Details
Keywords: Digital Transformation; Applications and Software; Product Development; Insurance; Policy; Health Industry; Germany
Related
  • 09 Aug 2016
  • First Look

August 9, 2016

https://www.hbs.edu/faculty/Pages/item.aspx?num=51304 The Impact of the Entry of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or... View Details
Keywords: Sean Silverthorne
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

broad-based therapies. Instead, the focus should be on enrolling subpopulations, based on diagnostic testing, in trials of targeted drug treatments and on monitoring and assessing effectiveness after drugs... View Details
Keywords: Martha Lagace
  • 16 Dec 2014
  • First Look

First Look: December 16

Michael E., and Robert S. Kaplan Abstract—Improving provider incentives and reimbursement must become a central component in health care reform. Reimbursement through bundled payments-a single payment that... View Details
Keywords: Sean Silverthorne
  • Web

Information Technology - Institute For Strategy And Competitiveness

Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Information Technology Information Technology To make the transformation to value-based health care... View Details
  • 15 Jul 2013
  • Research & Ideas

Five Imperatives for Improving Health Care

to be reimbursed very well by insurance companies, and they've set themselves up to do a lot of those particular procedures? "Those are two different scenarios, and we'd like to see more of the former than the latter." Promoting... View Details
Keywords: by Carmen Nobel; Health
  • 01 Sep 2023
  • News

Solving for Z

trauma, described how they overcame drug addiction, and talked about how they rebuilt their lives after a period of incarceration. And Chen has found that younger employees aren’t the only ones who appreciate feeling welcomed and... View Details
Keywords: Alexander Gelfand; Illustrations by Doug Chayka; Administration of Human Resource Programs; Government
  • Web

Industry Information - Alumni

health policy, reimbursement and payment models, population health and care quality, technology and data analytics, workflow improvements, management tactics and more . Look for targeted news in industries like Biotech, Health IT and... View Details
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

worldwide pharmaceuticals spending, according to Food and Drug Administration Commissioner Mark McClellan.) One problem, several panelists noted, is that European healthcare systems do not reimburse the high... View Details
Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology
  • 01 Sep 2008
  • News

Mara Aspinall

higher efficacy rate — 80 percent or more. Is 80 percent efficacy unusual for drugs currently on the market? Across all patients and diseases, drug efficacy averages 50 percent, so half the time they bring... View Details
Keywords: Deborah Blagg; Ambulatory Health Care Services; Health, Social Assistance
  • 08 Apr 2009
  • Research & Ideas

Clayton Christensen on Disrupting Health Care

describe it—in a way that applies to health care or any industry—is innovation that transforms a product or service that historically has been very complicated and expensive into something that is affordable and simple to use. Q: In your book, you identify... View Details
Keywords: by Deborah Blagg; Health
  • Web

Propose an Independent Project | MBA

senior manager to serve as the student team’s liaison. This person is expected to provide access to managers and information relevant to the project and should maintain a close connection with the team throughout the process. A budget and method for View Details
  • Web

1.18 Field Global Capstone | MBA

choice of location(s) for coursework participation, whichever is the least-restrictive reasonable alternative. Drug & Alcohol Policy The HBS Drug & Alcohol Policy states expectations for responsible alcohol... View Details
  • 01 Mar 2009
  • News

A New Approach to Health-Care Reform

that is affordable and simple to use. In your book, you identify fee-for-service reimbursement as a “runaway reactor” in accelerating the rise in health-care costs. Why is this system such a problem? By some estimates, 50 percent of all... View Details
Keywords: Deborah Blagg; Health, Social Assistance
  • 01 Jun 2002
  • News

Up to the Challenge: Lori Schock - Listen and Learn

insists, “it's theirs.” One opinion that was heard loud and clear during Schock's SA service was a call for a new prescription drug plan for HBS students. Schock was among student leaders who met with University health officials and the... View Details
Keywords: Kathleen Brill
  • 16 Jul 2008
  • Op-Ed

What Should Employers Do about Health Care?

frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
Keywords: by Michael E. Porter, Elizabeth O. Teisberg & Scott Wallace; Health